These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16760720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF.
    Chin Med J (Engl); 2007 Apr 20; 120(8):696-702. PubMed ID: 17517187
    [Abstract] [Full Text] [Related]

  • 3. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC, Sales VL, Mayer JE, Sacks MS.
    Biomaterials; 2006 Dec 20; 27(36):6083-95. PubMed ID: 16930686
    [Abstract] [Full Text] [Related]

  • 4. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
    Knight RL, Booth C, Wilcox HE, Fisher J, Ingham E.
    J Heart Valve Dis; 2005 Nov 20; 14(6):806-13. PubMed ID: 16359063
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells can be differentiated into endothelial cells in vitro.
    Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C.
    Stem Cells; 2004 Nov 20; 22(3):377-84. PubMed ID: 15153614
    [Abstract] [Full Text] [Related]

  • 6. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A, Wautot F, Juthier F, Fouquet O, Corseaux D, Marechaux S, Le Tourneau T, Fabre O, Susen S, Van Belle E, Mouquet F, Decoene C, Prat A, Jude B.
    J Thorac Cardiovasc Surg; 2007 Aug 20; 134(2):424-32. PubMed ID: 17662783
    [Abstract] [Full Text] [Related]

  • 7. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.
    Zhang J, Qi H, Wang H, Hu P, Ou L, Guo S, Li J, Che Y, Yu Y, Kong D.
    Artif Organs; 2006 Dec 20; 30(12):898-905. PubMed ID: 17181830
    [Abstract] [Full Text] [Related]

  • 8. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC, Sacks MS, Schoen FJ, Mayer JE.
    Circulation; 2005 May 31; 111(21):2783-91. PubMed ID: 15927990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Flow-dependent re-endothelialization of tissue-engineered heart valves.
    Lichtenberg A, Cebotari S, Tudorache I, Sturz G, Winterhalter M, Hilfiker A, Haverich A.
    J Heart Valve Dis; 2006 Mar 31; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
    [Abstract] [Full Text] [Related]

  • 11. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A.
    Circulation; 2006 Jul 04; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [Abstract] [Full Text] [Related]

  • 12. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R, Lueders C, Kraemer L, Kuebler W, Shakibaei M, Reichart B, Daebritz S, Hetzer R.
    Ann Thorac Surg; 2006 Jun 04; 81(6):2207-16. PubMed ID: 16731156
    [Abstract] [Full Text] [Related]

  • 13. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI.
    Circulation; 2002 Sep 24; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of recellularization level of bioprosthetic valve scaffold with AGNO3 staining technique in vitro].
    Feng B, Liu Y, Xie N.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Nov 24; 19(11):910-4. PubMed ID: 16334242
    [Abstract] [Full Text] [Related]

  • 17. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
    Roh JD, Brennan MP, Lopez-Soler RI, Fong PM, Goyal A, Dardik A, Breuer CK.
    J Pediatr Surg; 2007 Jan 24; 42(1):198-202. PubMed ID: 17208565
    [Abstract] [Full Text] [Related]

  • 18. Heart valve engineering: decellularized aortic homograft seeded with human cardiac stromal cells.
    Dainese L, Guarino A, Burba I, Esposito G, Pompilio G, Polvani G, Rossini A.
    J Heart Valve Dis; 2012 Jan 24; 21(1):125-34. PubMed ID: 22474754
    [Abstract] [Full Text] [Related]

  • 19. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J.
    Scand J Clin Lab Invest; 2008 Jan 24; 68(3):192-203. PubMed ID: 17852829
    [Abstract] [Full Text] [Related]

  • 20. Construction of autologous human heart valves based on an acellular allograft matrix.
    Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A.
    Circulation; 2002 Sep 24; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.